MarketCap
Repligen Corporation RGEN
$ 132.02
-1.15%
Facebook
X
Telegram
Repligen Corporation Cost of Revenue | RGEN
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Repligen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 352 M | 360 M | 354 M | 346 M | 279 M | 157 M | 119 M | 86.5 M | 67 M | 47.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 360 M | 47.1 M | 217 M |
Quarterly Cost of Revenue Repligen Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86 M | 88.3 M | 91.2 M | 78.4 M | - | 77.4 M | 77.3 M | 76.4 M | - | 105 M | 79.3 M | 81.8 M | - | 86.5 M | 86.3 M | 82.4 M | - | 75.5 M | 62 M | 59.7 M | - | 39.6 M | 36.9 M | 32 M | - | 31.4 M | 30.7 M | 26.8 M | - | 22.2 M | 21.1 M | 19.7 M | - | 20 M | 13.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 105 M | 13.9 M | 58.8 M |
Cost of Revenue of other stocks in the Medical instruments industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
107 K | - | - | $ 810 M |  USA |
 |
Ekso Bionics Holdings
EKSO
|
5.95 M | - | - | $ 28.6 M | USA |
 |
Isoray
ISR
|
2.74 M | - | 0.03 % | $ 108 M | USA |
 |
Predictive Oncology
POAI
|
72.6 K | - | - | $ 31.1 M | USA |
 |
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | USA |
 |
Alcon
ALC
|
3.58 B | $ 64.68 | 0.84 % | $ 40.4 B |  Schweiz |
 |
AngioDynamics
ANGO
|
135 M | $ 12.15 | 3.49 % | $ 496 M | USA |
 |
AtriCure
ATRC
|
134 M | $ 28.8 | 6.19 % | $ 1.38 B | USA |
 |
Baxter International
BAX
|
7.86 B | $ 19.89 | 2.58 % | $ 10.2 B | USA |
 |
Becton, Dickinson and Company
BDX
|
11.9 B | $ 143.98 | 1.67 % | $ 41.4 B | USA |
 |
BioLife Solutions
BLFS
|
34.1 M | $ 26.04 | 1.8 % | $ 1.24 B | USA |
 |
The Cooper Companies
COO
|
1.41 B | $ 65.91 | 1.32 % | $ 13.1 B | USA |
 |
electroCore
ECOR
|
4.24 M | $ 8.43 | -3.11 % | $ 71.5 K | USA |
 |
Glaukos Corporation
GKOS
|
112 M | $ 130.68 | 2.57 % | $ 7.47 B | USA |
 |
Haemonetics Corporation
HAE
|
546 M | $ 74.17 | 1.98 % | $ 3.5 B | USA |
 |
Harvard Bioscience
HBIO
|
36.6 M | $ 5.87 | -2.17 % | $ 261 M | USA |
 |
ICU Medical
ICUI
|
1.41 B | $ 140.37 | 1.76 % | $ 3.46 B | USA |
 |
InfuSystem Holdings
INFU
|
63.1 M | $ 9.42 | 7.66 % | $ 195 M | USA |
 |
iRhythm Technologies
IRTC
|
220 M | $ 104.65 | 2.81 % | $ 3.35 B | USA |
 |
Intuitive Surgical
ISRG
|
3.42 B | $ 406.78 | 1.14 % | $ 145 B | USA |
 |
Repro Med Systems
KRMD
|
15.5 M | $ 3.9 | 0.52 % | $ 180 M | USA |
 |
LeMaitre Vascular
LMAT
|
71.1 M | $ 93.95 | 1.89 % | $ 2.13 B | USA |
 |
Masimo Corporation
MASI
|
1.09 B | $ 179.95 | - | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
2.07 M | $ 1.86 | -1.06 % | $ 85.2 M |  Israel |
 |
Milestone Scientific
MLSS
|
2.57 M | $ 0.37 | 8.89 % | $ 30.4 M | USA |
 |
Merit Medical Systems
MMSI
|
778 M | $ 67.22 | 3.03 % | $ 3.98 B | USA |
 |
Nephros
NEPH
|
7.16 M | $ 3.15 | -1.56 % | $ 33.4 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.23 B | $ 25.91 | 4.22 % | $ 4.35 B | USA |
 |
OraSure Technologies
OSUR
|
66.8 M | $ 4.25 | -4.92 % | $ 312 M | USA |
 |
Pro-Dex
PDEX
|
47.1 M | $ 64.37 | 6.47 % | $ 212 M | USA |
 |
Pulse Biosciences
PLSE
|
539 K | $ 25.6 | 0.59 % | $ 1.73 B | USA |
 |
ResMed
RMD
|
1.55 B | $ 188.63 | 1.26 % | $ 27.6 B | USA |
 |
Retractable Technologies
RVP
|
38.2 M | $ 0.67 | - | $ 20.1 M | USA |
 |
STAAR Surgical Company
STAA
|
57 M | $ 29.12 | -0.34 % | $ 1.44 B | USA |
 |
STERIS plc
STE
|
3.31 B | $ 202.61 | 1.61 % | $ 19.9 B | USA |
 |
Stereotaxis
STXS
|
15.3 M | $ 1.88 | 5.32 % | $ 171 M | USA |
 |
Teleflex Incorporated
TFX
|
872 M | $ 127.0 | 1.63 % | $ 5.67 B | USA |
 |
Utah Medical Products
UTMD
|
16.5 M | $ 67.04 | 2.04 % | $ 217 M | USA |
 |
West Pharmaceutical Services
WST
|
1.97 B | $ 327.95 | 1.35 % | $ 23.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.84 B | $ 10.33 | 2.99 % | $ 2.06 B | USA |